Sirona Biochem (TSE:SBM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sirona Biochem Corp. partners with Stonegate Healthcare Partners to boost business development and investor relations, focusing on their innovative anti-aging ingredient, GlycoProteMim. The collaboration aims to tap into Stonegate’s vast network and expertise to enhance GlycoProteMim’s market presence in the skincare industry. This strategic partnership is expected to elevate Sirona’s global reach and accelerate the commercialization of their proprietary anti-aging solutions.
For further insights into TSE:SBM stock, check out TipRanks’ Stock Analysis page.